Immunoassay
NEONATAL PKU Screening Assay is a quantitative enzyme assay used in phenylketonuria (PKU) newborn screening. It's a PKU test for newborns that quantifies an abnormal concentration of phenylalanine in dried blood samples on 903® or 226 blotting paper.
In the first reaction of the NEONATAL PKU Screening Assay, an enzyme, phenylalanine dehydrogenase, converts phenylalanine contained in the sample to phenylpyruvate and NADH. Thereafter, the presence of NADH is quantified by colorimetry using tetrazolium salt. The measured absorbance intensity is then proportional to the phenylalanine concentration in the sample.
The kit is for phenylketonuria (PKU) newborn screening
Product code
NEONATAL MSUD Screening Assay is a quantitative enzymatic test that assays leukine, one of the 3 amino acids accumulated in maple syrup urine disease (MSUD) also known as ketoacidemia or branched-chain amino acids (BCAAs). This test is for maple syrup urine disease newborn screening, and is performed using dried blood samples on 903® or 226 type blotting paper.
The Immunomat™ is intended for neonatal screening laboratories performing between 400 and 1000 daily determinations. With a maximum capacity of 7 microplates, it optimizes the rate of the laboratory by allowing the processing of different parameters in parallel.